Skip to content

Safety and efficacy of high-flow nasal cannula vs noninvasive ventilation after extubation in elderly patients with chronic obstructive pulmonary disease: a non-inferiority randomized controlled trial

Safety and efficacy of high-flow nasal cannula vs noninvasive ventilation after extubation in elderly patients with chronic obstructive pulmonary disease: a non-inferiority randomized controlled trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087312
Enrollment
Unknown
Registered
2024-07-24
Start date
2024-07-19
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Experimental group (HFNC group):The patient received HFNC immediately after extubation.
Control group (NIV):The patient received NIV immediately after extubation.

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Patients with COPD who meet the criteria of global initiative for chronic obstructive lung disease (GLOD) standard of patients with COPD (2) Age > 65 years old (3) Respiratory failure is caused by bronchial or lung infection and meets the criteria for pulmonary infection control window

Exclusion criteria

Exclusion criteria: (1) Patients with tracheotomy (2) Accompanied by serious dysfunction of other organs, such as heart, brain, kidney and liver failure (3) There are contraindications to NIV, such as esophageal surgery in recent esophageal patients, facial trauma/postoperative/malformation (4) Poor prognosis or palliative care is expected in the short term (5) Unable to obtain informed consent from family members/individuals

Design outcomes

Primary

MeasureTime frame
Reintubation rate 72 hours and 7 days after extubation;

Secondary

MeasureTime frame
Treatment failure rate (including reintubation rate and replacement of respiratory support);Vital signs and arterial blood gas;Patient compliance and comfort scores;Duration of respiratory support after extubation;Adverse event;Patient sleep quality score;Use of sedative and analgesic drugs after extubation;Incidence of post-extubation delirium;Prognosis: 28-day mortality rate, ICU stay and ICU death rate, hospital stay and hospital death rate, mechanical ventilation time of survivors, tracheotomy rate;

Countries

China

Contacts

Public ContactGuopeng Liang

West China Hospital, Sichuan University

liangguopeng007@163.com+86 189 8060 6154

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026